Alpha Tau Medical
(NASDAQ) DRTS
Alpha Tau Medical Financials at a Glance
Market Cap
$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$56.88M
EPS (TTM)
-$0.66
P/E Ratio
-19.32
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$12.80
Volume
12,456
Open
$12.37
Price
$12.80
Volume
12,456
Open
$12.37
Previous Close
$12.80
Daily Range
$12.34 - $13.05
52-Week Range
$2.87 - $14.11
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$12.80
Volume
12,456
Open
$12.37
Previous Close
$12.80
Daily Range
$12.34 - $13.05
52-Week Range
$2.87 - $14.11
Estimated Earnings Date
Aug 10, 2026
DRTS News
DRTS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alpha Tau Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
112
CEO
Uzi Sofer, MBA
Website
www.alphatau.comHeadquarters
Jerusalem, JM 9777605, IL
DRTS Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-73.23%
Return on Capital
-46.56%
Return on Assets
-52.29%
Earnings Yield
-5.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
88.01M
Volume
12.46K
Avg. Volume
858.17K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$46.29M
EBITDA
-$44.93M
Operating Cash Flow
-$26.68M
Capital Expenditure
-$6.08M
Free Cash Flow
-$32.76M
Cash & ST Invst.
$80.23M
Total Debt
$14.34M
Alpha Tau Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$9.51M
N/A
Employees
118
N/A
Net Income
-$22.94M
-163.9%
EBITDA
-$13.31M
-43.0%
Quarterly Fundamentals
Total Cash
$80.23M
+55.4%
Total Debt
$14.34M
+16.7%
Accounts Receivable
$1.12M
-42.2%
Inventory
$0.00
N/A
Long Term Debt
$13.14M
+16.4%
Short Term Debt
$1.20M
+20.0%
Return on Assets
-52.29%
N/A
Return on Invested Capital
-47.08%
N/A
Free Cash Flow
-$32.76M
N/A
Operating Cash Flow
-$26.68M
N/A